Evaluation and Management of Increased Vaginal Discharge
Increased vaginal discharge requires immediate evaluation with vaginal pH testing and microscopic examination of the discharge to identify the three most common infectious causes: bacterial vaginosis, trichomoniasis, and vulvovaginal candidiasis, which together account for the vast majority of pathological vaginal discharge cases. 1
Diagnostic Approach
Initial Assessment
Perform a speculum examination and collect vaginal discharge samples for immediate point-of-care testing 1:
Measure vaginal pH using narrow-range pH paper. A pH >4.5 indicates bacterial vaginosis or trichomoniasis, while pH ≤4.5 suggests vulvovaginal candidiasis 1
Prepare two wet mount slides: Mix one sample with 1-2 drops of 0.9% normal saline and another with 10% potassium hydroxide (KOH) 1
Perform the "whiff test": An amine (fishy) odor immediately after applying KOH indicates bacterial vaginosis or trichomoniasis 1
Microscopic examination:
Common Infectious Causes
Recent hospital-based data shows trichomoniasis is the most common infection (40.5%), followed by bacterial vaginosis (22.8%) and vulvovaginal candidiasis (13.0%) 2. However, bacterial vaginosis remains the most prevalent cause of vaginal discharge overall in most populations 1.
Treatment by Diagnosis
Bacterial Vaginosis
Treat only symptomatic women with one of these CDC-recommended regimens 1:
- Metronidazole 500 mg orally twice daily for 7 days (preferred for reliability)
- Metronidazole gel 0.75% intravaginally once daily for 5 days
- Clindamycin cream 2% intravaginally at bedtime for 7 days
Partner treatment is NOT recommended as it does not prevent recurrence 1. Follow-up is unnecessary if symptoms resolve 1.
Trichomoniasis
Treat with metronidazole 2 g orally as a single dose (90-95% cure rate) 1. Alternative: metronidazole 500 mg twice daily for 7 days 1.
Critical management points:
- Treat all sexual partners simultaneously to prevent reinfection 1
- Instruct patients to avoid sexual intercourse until both patient and partner complete treatment and are asymptomatic 1
- Topical metronidazole gel is ineffective (<50% cure rate) and should NOT be used 1
Vulvovaginal Candidiasis
For uncomplicated cases, use short-course topical azole therapy (80-90% effective) 1:
- Fluconazole 150 mg oral tablet, single dose (most convenient) 1
- Clotrimazole 1% cream 5 g intravaginally for 7-14 days 1
- Miconazole 2% cream 5 g intravaginally for 7 days 1
- Single-dose intravaginal preparations (clotrimazole 500 mg tablet, tioconazole 6.5% ointment) 1
Partner treatment is NOT necessary as candidiasis is not sexually transmitted 1.
Special Populations
Pregnant Women
All symptomatic pregnant women require treatment due to associations with adverse pregnancy outcomes 1:
- Bacterial vaginosis: Oral metronidazole or clindamycin (avoid first trimester concerns with proper counseling; metronidazole is safe throughout pregnancy per multiple meta-analyses) 1
- Trichomoniasis: Metronidazole 2 g single dose is safe and recommended 1
- Candidiasis: Topical azole therapy only; avoid oral fluconazole 1
Follow-up evaluation 1 month after treatment completion is essential in pregnant women to verify cure 1.
HIV-Infected Women
Treat with identical regimens as HIV-negative women for all three conditions 1.
When Diagnosis Remains Unclear
If microscopy is negative but symptoms persist:
- Order culture for T. vaginalis (more sensitive than microscopy at 60-70% sensitivity) 1
- Consider cervicitis from Chlamydia trachomatis or Neisseria gonorrhoeae, which can present as vaginal discharge 1, 3, 4
- Approximately 9.5% of cases represent physiological discharge requiring no treatment 2
Critical Pitfalls to Avoid
- Never treat asymptomatic candidiasis identified on culture or microscopy, as 10-20% of women normally harbor Candida species 1
- Never use topical metronidazole for trichomoniasis due to poor efficacy 1
- Never skip partner treatment for trichomoniasis, as this leads to treatment failure and reinfection 1
- Do not rely solely on syndromic management without microscopy, as this results in significant overtreatment and missed diagnoses 5, 6